Dr. Brian Scott, MD
Claim this profileStanford Cancer Institute
Studies Glioblastoma
Studies Brain and Nervous System
3 reported clinical trials
6 drugs studied
Area of expertise
1Glioblastoma
Stage II
Stage I
2Brain And Nervous System
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Brian Scott, MD is currently running
CAR T-Cell Therapy
for Brain Cancer
This is an open label, non-randomized, single site Phase I study to test the manufacturing feasibility and safety of locoregional (LR) administration of B7-H3CART into the central nervous system of adult subjects with recurrent IDH wild-type GBM using a standard 3+3 dose escalation design.
Recruiting1 award Phase 1
GD2 CAR T Cells
for Brain and Spinal Cord Gliomas
The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) or spinal H3K27M-mutant diffuse midline glioma (DMG). H3K27Mmutant testing will occur as part of standard of care prior to enrollment.
Recruiting1 award Phase 18 criteria
More about Brian Scott, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Brian Scott, MD has experience with
- B7-H3CART
- Cyclophosphamide
- Fludarabine
- GD2 CAR T Cells
- Axicabtagene Ciloleucel
- Neuropsychological Testing
Breakdown of trials Brian Scott, MD has run
Glioblastoma
Brain and Nervous System
Diffuse Intrinsic Pontine Glioma
Brain Stem Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian Scott, MD specialize in?
Brian Scott, MD focuses on Glioblastoma and Brain and Nervous System. In particular, much of their work with Glioblastoma has involved Stage II patients, or patients who are Stage I.
Is Brian Scott, MD currently recruiting for clinical trials?
Yes, Brian Scott, MD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Brian Scott, MD has studied deeply?
Yes, Brian Scott, MD has studied treatments such as B7-H3CART, Cyclophosphamide, Fludarabine.
What is the best way to schedule an appointment with Brian Scott, MD?
Apply for one of the trials that Brian Scott, MD is conducting.
What is the office address of Brian Scott, MD?
The office of Brian Scott, MD is located at: Stanford Cancer Institute, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.